1496
A. Mobinikhaledi, A. K. Amiri
Entry 10: (2Z,5Z)-5-(1H-indole-3-yl)methylene)-3-(4-butylphenyl)-2-(4-butylphe-
nylimino) thiazolidin-4-one 1H NMR (300 MHz, CDCl3): d = 0.93 (t, 6H,
J = 7.7 Hz), 1.28–1.45 (m, 4H), 1.57–1.68 (m, 4H), 2.61–2.66 (m, 4H),
6.94–7.85 (m, 13H), 8.18 (s, 1H), 8.91 (1H, brs, NH); 13C NMR (75 MHz, CDCl3):
d = 13.9, 14.0, 22.3, 22.4, 33.2, 33.6, 35.1, 35.4, 111.6, 112.4, 115.8, 118.7, 121.0,
121.4, 123.2, 123.6, 126.5, 127.0, 127.7, 129.1, 129.2, 132.5, 135.7, 139.3, 143.6,
146.2, 151.3, 166.8; IR (KBr, cm-1): 1,637 (C=N), 1,689 (C=O), 3,263 (NH), Anal.
Calcd for C32H33N3OS: C, 75.70; H, 6.55; N, 8.28; S, 6.32. Found: C, 75.94; H,
6.39; N, 8.34; S, 6.49.
Entry 11: (2Z,5Z)-5-(4-chlorobenzylidene)-3-(2,3-dimethylphenyl)-2-(2,3-dimethyl-
phenylimino)thiazolidin-4-one 1H NMR (300 MHz, CDCl3): d = 2.06 (s, 3H),
2.23 (s, 3H), 2.31 (s, 3H), 2.40 (s, 3H), 6.74–7.41 (m, 10H), 7.80 (s, 1H); 13C NMR
(75 MHz, CDCl3): d = 13.9, 14.4, 20.3, 20.5, 117.9, 122.1, 125.9, 126.0, 126.7,
126.8, 128.3, 129.3, 130.0, 131.3, 131.4, 132.1, 133.8, 134.7 (CH=C), 135.8, 137.9,
138.6, 146.5, 150.2 (C=N), 166.2 (C=O); IR (KBr, cm-1): 1,649 (C=N), 1,720
(C=O), Anal. Calcd for C26H23N2OSCl: C, 69.86; H, 5.19; N, 6.27; S, 7.17. Found:
C, 70.05; H, 5.01; N, 6.22; S, 7.34.
Entry 12: (2Z,5Z)-5-(2-hydroxybenzylidene)-3-(2,3-dimethylphenyl)-2-(2,3-dimeth-
ylphenylimino)thiazolidin-4-one 1H NMR (300 MHz, DMSO-d6): d = 1.96 (s,
3H), 2.11 (s, 3H), 2.22 (s, 3H), 2.33 (s, 3H), 6.67–7.28 (m, 10H), 8.03 (s, 1H), 10.49
(1H, brs, OH); 13C NMR (75 MHz, DMSO-d6): d = 13.9, 14.4, 20.3, 20.5, 116.4,
117.9, 120.1, 120.3, 120.7, 126.3, 126.4, 126.6, 126.7, 127.0, 127.8, 128.8, 131.0,
132.3, 134.8 (CH=C),135.0, 137.9, 138.3, 147.0, 150.2 (C=N), 157.3, 166.1 (C=O);
IR (KBr, cm-1): 1,646 (C=N), 1,715 (C=O), 3,221 (brs, OH), Anal. Calcd for
C26H24N2O2S: C, 72.87; H, 5.64; N, 6.54; S, 7.48. Found: C, 72.70; H, 5.50; N,
6.69; S, 7.42.
Entry 13: (2Z,5Z)-5-(2,4-dihydroxybenzylidene)-3-(2,3-dimethylphenyl)-2-(2,3-dim-
ethylphenylimino)thiazolidin-4-one 1H NMR (300 MHz, DMSO): d = 1.91 (s,
3H), 2.08 (s, 3H), 2.20 (s, 3H), 2.23 (s, 3H), 6.41–7.29 (m, 9H), 7.98 (s, 1H), 10.20
(brs, OH), 10.43(brs, OH); 13C NMR (75 MHz, CDCl3): d = 13.8, 14.3, 19.0, 20.3,
117.8, 126.1, 126.2, 126.6, 126.9, 127.5, 130.7,135.0, 135.1, 137.7, 138.2, 147.1,
155.1, 171.9 (C=O); IR (KBr, cm-1): 1,691 (C=N), 1,712 (C=O), 3,381 (OH), Anal.
Calcd for C26H24N2O3S: C, 70.25; H, 5.44; N, 6.30; S, 7.21. Found: C; 70.48; H,
5.59; N, 6.39; S, 7.02.
Entry 14: (2Z,5Z)-5-benzylidene-3-(2,4,6-trimethylphenyl)-2-(2,4,6-trimethylphe-
nylimino) thiazolidin-4-one 1H NMR (300 MHz, CDCl3): d = 1.97 (s, 6H), 2.12
(s, 6H), 2.30 (s, 3H), 2.45 (s, 3H), 6.82–7.63 (m, 9H), 7.90 (s, 1H); 13C NMR
(75 MHz, CDCl3): d = 17.7, 18.3, 20.9, 21.3, 121.3, 128.1, 128.4, 129.0, 129.1,
129.7, 129.9, 130.1, 131.5, 133.6, 133.9, 135.8 (CH=C), 139.6, 143.3, 151.0 (C=N),
166.1 (C=O); IR (KBr, cm-1): 1,645 (C=N), 1,720 (C=O), Anal. Calcd for
123